Success Inter Link PTE Limited Pharmaceutical Import Profile — Singapore (DGFT 2022–2026)

Name: Success Inter Link PTE Limited Pharmaceutical Import Records from India — 4 Products, $489.1K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Success Inter Link PTE Limited — Pharmaceutical Importer Profile (2026) | 4 Products, $489.1K Trade | TransData Nexus

Success Inter Link PTE Limited

Pharmaceutical Importer · Singapore · Advanced Diabetes Medications Focus · $489.1K Total Trade · DGFT Verified

Success Inter Link PTE Limited is a pharmaceutical importer based in Singapore with a total trade value of $489.1K across 4 products in 2 therapeutic categories. Based on 51 verified import shipments from Indian Customs (DGFT) records, Success Inter Link PTE Limited is the #1 buyer in 1 product including Canagliflozin. Success Inter Link PTE Limited sources from 10 verified Indian suppliers, with Shree Ssd Pharma Private Limited accounting for 31.4% of imports.

Success Inter Link PTE Limited — Import Portfolio & Supplier Network

Success Inter Link PTE Limited import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Success Inter Link PTE Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Shree Ssd Pharma Private Limited	$764.9K	455	31.4%
Lotus International	$584.8K	336	24.0%
Ganpati Exim Inc

What Formulations Does Success Inter Link PTE Limited Import?

Formulation	Value	Ships
Pharmaceuticals article / ods / product / item veltride 0.5 mgtabsdutasteride100	$50.2K	2
Finpecia 1MG TAB finasteride 1MG	$50.0K	1
Finpecia 1MG TAB finasteride 1MG	$50.0K	1
Finpecia 1MG TAB finasteride 1MG	$50.0K	1
Pharmaceutical product medicine packof 100 TAB dutasteride tablets 0.5 MG	$50.0K	1
Olopatadine hcl IP 5MG Pack of 100	$50.0K	1
Pharmaceutical product medicine:Pack of 100 TAB dutasteride 0.5 MG	$50.0K	1
Finasteride IP 1 MG Pack of 150	$50.0K	1
Dutasteride IP 0.5 MG Pack of 100	$50.0K	1
Pharmaceuticals products veltride 0.5 mgtabsdutasteride100	$50.0K	1
Contain medicines harmless pharmaceutical article / ods / product / item - details as per attached export annexure invoice no : pgpl/081	$49.9K	2
Pharmaceutical product medicine packof 100 TAB dutasteride 0.5 MG	$49.7K	1
Valacyclovir hydrochloride IP equivalent to valacyclovir 1000MG Pack of 15	$48.9K	1
Pharmaceuticals products duman 0.5 MG tabsdutasteride100	$37.8K	2
Contain medicines harmless pharmaceutical article / ods / product / item - details as per attached export annexure invoice no : pgpl/081	$36.5K	6

Success Inter Link PTE Limited imports 979 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Canagliflozin	Advanced Diabetes Medications	$225.2K	16	19.6%	1
2	Linagliptin	Advanced Diabetes Medications	$141.9K	19	2.8%	2
3	Empagliflozin	Diabetes & Endocrine	$109.6K	12	1.6%	11
4	Saxagliptin	Advanced Diabetes Medications	$12.3K	4	0.3%	7

Success Inter Link PTE Limited imports 4 pharmaceutical products across 2 categories into Singapore totaling $489.1K. The company is the #1 buyer for 1 product: Canagliflozin.

Success Inter Link PTE Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Success Inter Link PTE Limited, established on 17 February 2011, is a Singapore-based private company specializing in the import and export of medicinal and pharmaceutical products, including cosmetics and health supplements. The company operates from its registered office at 180 Cecil Street, #12-02, Bangkok Bank Building, Singapore 069546. (companies.sg) With a paid-up capital of SGD 800,000, Success Inter Link PTE Limited has been operational for over 14 years, indicating a stable presence in the pharmaceutical import sector.

As a pharmaceutical importer, Success Inter Link PTE Limited plays a crucial role in Singapore's healthcare supply chain by sourcing and distributing a range of medicinal products. The company's focus on importing finished pharmaceutical formulations, such as tablets, capsules, syrups, and injections, underscores its commitment to providing ready-to-use medications to meet the diverse needs of the Singaporean market.

2Distribution Network

While specific details about Success Inter Link PTE Limited's warehouse locations and logistics capabilities are not publicly disclosed, the company's operations suggest a well-established distribution network within Singapore. The strategic location of its registered office in the central business district facilitates efficient access to key transportation hubs, enabling effective distribution across the island. The company's import activities, including 51 shipments from India, indicate a robust logistics framework capable of handling international trade efficiently.

3Industry Role

Success Inter Link PTE Limited functions primarily as a pharmaceutical importer and wholesaler in Singapore. By sourcing finished pharmaceutical formulations from various suppliers, the company ensures a steady supply of medications to meet the demands of healthcare providers and pharmacies across the country. Its role is pivotal in bridging the gap between international manufacturers and the local market, contributing to the availability of essential medicines in Singapore.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Success Inter Link PTE Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The company's sourcing strategy reveals a significant concentration on a select group of suppliers. Notably, the top five suppliers—SHREE SSD PHARMA PRIVATE LIMITED, LOTUS INTERNATIONAL, GANPATI EXIM INC, PARKSLEY GLOBAL PRIVATE LIMITED, and CIPLA LIMITED—account for a substantial portion of the total import value. This concentration suggests a strategic choice to establish strong, reliable partnerships with key suppliers, ensuring consistent product quality and supply. However, such dependency also poses a risk; any disruption with these suppliers could impact the company's ability to meet market demands. The high number of shipments from these suppliers indicates a stable and ongoing relationship, which may mitigate some of these risks.

2Supply Chain Resilience

Success Inter Link PTE Limited's supply chain resilience appears robust, given its diversified portfolio of 979 unique formulations sourced from 10 different Indian suppliers. This diversity in sourcing helps mitigate risks associated with over-reliance on a single supplier or product line. The company's focus on finished pharmaceutical formulations suggests a streamlined supply chain, potentially reducing complexities and enhancing responsiveness to market needs. While specific details about backup suppliers and shipping routes are not publicly available, the company's established relationships with multiple suppliers indicate a proactive approach to ensuring supply chain continuity.

Importing Pharmaceuticals into Singapore — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Singapore

1Regulatory Authority & Framework

In Singapore, the Health Sciences Authority (HSA) is the primary regulatory body overseeing the importation, supply, and manufacture of health products, including medicinal and pharmaceutical items. The HSA operates under the Health Products Act and the Medicines Act, ensuring that all health products meet standards of safety, quality, and efficacy. (moh.gov.sg) The regulatory framework requires that all medicines, including generics, undergo evaluation and approval by the HSA before they can be supplied in Singapore. (moh.gov.sg)

2Import Licensing & GMP

Importers of pharmaceutical products into Singapore must obtain the necessary approvals from the HSA. This includes ensuring that the products are registered with the HSA and that the manufacturing facilities comply with Good Manufacturing Practice (GMP) standards. The HSA recognizes GMP certificates from various international standards, including EU GMP, WHO GMP, and PIC/S, facilitating the importation of quality-assured products. (moh.gov.sg) Additionally, importers must hold a valid wholesale dealer's license to distribute pharmaceutical products within Singapore.

3Quality & Labeling

Success Inter Link PTE Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Success Inter Link PTE Limited's focus on importing advanced diabetes medications, such as Canagliflozin, Linagliptin, and Empagliflozin, aligns with the growing prevalence of diabetes in Singapore. The company's portfolio concentration in this therapeutic area indicates a strategic decision to address a significant health concern, catering to the substantial demand for effective diabetes treatments. The market demand for these products is driven by the increasing incidence of diabetes and the need for innovative therapies to manage the condition effectively.

2Sourcing Profile

The company's sourcing strategy emphasizes importing finished pharmaceutical formulations, particularly generics, from India. This approach allows Success Inter Link PTE Limited to offer cost-effective alternatives to branded medications, making treatments more accessible to a broader segment of the Singaporean population. India's established pharmaceutical manufacturing industry, known for its adherence to international quality standards, complements Success Inter Link PTE Limited's procurement strategy, ensuring a reliable supply of quality-assured products.

3Market Positioning

Seller's Guide — How to Become a Supplier to Success Inter Link PTE Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Success Inter Link PTE Limited, especially those offering advanced diabetes medications and other high-demand therapeutic products. Gaps in the company's current sourcing may exist in areas such as emerging therapeutic categories or innovative drug formulations. Indian exporters can explore these opportunities by ensuring compliance with Singapore's regulatory standards, providing competitive pricing, and demonstrating a commitment to quality and reliability.

2Requirements & Qualifications

Indian exporters seeking to supply Success Inter Link PTE Limited and the Singaporean market must ensure that their products are registered with the HSA and that their manufacturing facilities comply with recognized GMP standards, such as EU GMP, WHO GMP, or PIC/S. Additionally, exporters must provide evidence of product quality, including batch testing and stability data, and adhere to Singapore's labeling and serialization requirements. Holding a valid wholesale dealer's license is also essential for distributing pharmaceutical products within Singapore.

3How to Approach

Frequently Asked Questions — Success Inter Link PTE Limited

What products does Success Inter Link PTE Limited import from India?

Success Inter Link PTE Limited imports 4 pharmaceutical products across 2 categories. Top imports: Canagliflozin ($225.2K), Linagliptin ($141.9K), Empagliflozin ($109.6K), Saxagliptin ($12.3K).

Who supplies pharmaceuticals to Success Inter Link PTE Limited from India?

Success Inter Link PTE Limited sources from 10 verified Indian suppliers. The primary supplier is Shree Ssd Pharma Private Limited (31.4% of imports, $764.9K).

What is Success Inter Link PTE Limited's total pharmaceutical import value?

Success Inter Link PTE Limited's total pharmaceutical import value from India is $489.1K, based on 51 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Success Inter Link PTE Limited focus on?

Success Inter Link PTE Limited imports across 2 categories. The largest: Advanced Diabetes Medications (77.6%), Diabetes & Endocrine (22.4%).

Get Full Success Inter Link PTE Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.